Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear
In Brief: Sundwall Leaves Hatch to head HRSA; Terry Joins Damon Biotech; Irlin On Hunger Strike
14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement
NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer









